Clinical Trials Logo

Endometrial Hyperplasia clinical trials

View clinical trials related to Endometrial Hyperplasia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04897217 Withdrawn - Clinical trials for Endometrial Hyperplasia

Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

Start date: June 30, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare the uterus tissue of women who receive an intrauterine system to treat their endometrial hyperplasia with the uterine tissue of women who receive megestrol acetate to treat their hyperplasia. While both methods are commonly used in practice, investigators would like to see what effects each treatment has on uterine tissue.

NCT ID: NCT04683237 Withdrawn - Obese Clinical Trials

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Start date: March 20, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

To investigate the efficacy of liraglutide plus megestrol acetate in obesity patients with atypical endometrial hyperplasia (AEH)

NCT ID: NCT01943058 Withdrawn - Clinical trials for Endometrial Adenocarcinoma

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

Start date: March 2014
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well megestrol acetate or levonorgestrel-releasing intrauterine system works in treating patients with atypical endometrial hyperplasia or endometrial cancer. Progesterone can cause the growth of endometrial cancer cells. Hormone therapy using megestrol acetate or levonorgestrel-releasing intrauterine system may fight endometrial cancer by lowering the amount of progesterone the body makes. It is not yet known whether megestrol acetate is more effective than levonorgestrel-releasing intrauterine system in treating atypical endometrial hyperplasia or endometrial cancer.

NCT ID: NCT00123175 Withdrawn - Clinical trials for Endometrial Hyperplasia

Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)

Start date: September 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this research is to determine the effectiveness of the intrauterine device (IUD) called Mirena when compared to the Provera tablets used in treating this condition.